ORANGE COUNTY EARNINGS

Cortex Pharmaceuticals Inc.: The Irvine developer of drug therapies for neurological and psychiatric disorders reported net income of $979,224, or 6 cents a share, for the third fiscal quarter, contrasted with a net loss of $1.5 million, or 15 cents a share, for the corresponding previous-year period. Revenue for the quarter ended March 31 rose to $2.5 million from $80,000.